BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16012746)

  • 1. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk.
    Singal R; Das PM; Manoharan M; Reis IM; Schlesselman JJ
    Oncol Rep; 2005 Aug; 14(2):569-73. PubMed ID: 16012746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R; Ferdinand L; Reis IM; Schlesselman JJ
    Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].
    Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk.
    Singal R; Ferdinand L; Das PM; Reis IM; Schlesselman JJ
    Int J Oncol; 2004 Nov; 25(5):1465-71. PubMed ID: 15492840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered methylation of multiple genes in carcinogenesis of the prostate.
    Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T
    Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites.
    Woodson K; Hayes R; Wideroff L; Villaruz L; Tangrea J
    Prostate; 2003 May; 55(3):199-205. PubMed ID: 12692786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality.
    Zelic R; Fiano V; Ebot EM; Coseo Markt S; Grasso C; Trevisan M; De Marco L; Delsedime L; Zugna D; Mucci LA; Richiardi L
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):284-291. PubMed ID: 30341411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
    Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
    Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of DNA methylation in multifocal prostate cancer.
    Serenaite I; Daniunaite K; Jankevicius F; Laurinavicius A; Petroska D; Lazutka JR; Jarmalaite S
    Virchows Arch; 2015 Jan; 466(1):53-9. PubMed ID: 25369892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of cigarette smoking, DNA methyltransferase 3B genetic polymorphism, and DNA damage on lung cancer.
    Huang CC; Lai CY; Tsai CH; Wang JY; Wong RH
    BMC Cancer; 2021 Sep; 21(1):1066. PubMed ID: 34587932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
    Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of DNMT3B -149C>T and -2437T>A polymorphisms and lung cancer risk in Chinese population.
    Gao M; He D; Meng F; Li J; Shen Y
    World J Surg Oncol; 2016 Nov; 14(1):293. PubMed ID: 27876061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMT3B promoter polymorphism and risk of gastric cancer.
    Hu J; Fan H; Liu D; Zhang S; Zhang F; Xu H
    Dig Dis Sci; 2010 Apr; 55(4):1011-6. PubMed ID: 19517237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of MTHFR DNMT3b 4977 bp deletion in mtDNA and GSTM1 deletion, and aberrant CpG island hypermethylation of GSTM1 in non-obstructive infertility in Indian men.
    Dhillon VS; Shahid M; Husain SA
    Mol Hum Reprod; 2007 Apr; 13(4):213-22. PubMed ID: 17277043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphisms of DNA methyltransferases and the risk of prostate cancer].
    He BS; Pan YQ; Zhu CB
    Zhonghua Nan Ke Xue; 2014 Dec; 20(12):1077-81. PubMed ID: 25597172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes.
    Naghibalhossaini F; Mokarram P; Khalili E; Naghibalhossaini S
    Cancer Biomark; 2015; 15(3):227-33. PubMed ID: 25769449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Pookot D; Li LC; Tabatabai ZL; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Int J Cancer; 2005 Aug; 116(2):174-81. PubMed ID: 15800905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.